Cargando…
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack
Here, in Part II of a duology on the characterization and potential treatment for COVID-19, we characterize the application of an innovative treatment regimen for the prevention of the transition from mild to severe COVID-19, as well as detail an intensive immunotherapy intervention hypothesis. We p...
Autores principales: | Frohman, Elliot M., Villemarette-Pittman, Nicole R., Cruz, Roberto Alejandro, Longmuir, Reid, Rowe, Vernon, Rowe, Elizabeth S., Varkey, Thomas C., Steinman, Lawrence, Zamvil, Scott S., Frohman, Teresa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241359/ https://www.ncbi.nlm.nih.gov/pubmed/32534807 http://dx.doi.org/10.1016/j.jns.2020.116935 |
Ejemplares similares
-
Part I. SARS-CoV-2 triggered ‘PANIC’ attack in severe COVID-19
por: Frohman, Elliot M., et al.
Publicado: (2020) -
Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease()
por: Frohman, Elliot M., et al.
Publicado: (2021) -
Mitigating alemtuzumab-associated autoimmunity in MS: A “whack-a-mole” B-cell depletion strategy
por: Meltzer, Ethan, et al.
Publicado: (2020) -
Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?
por: Maguire, Cole, et al.
Publicado: (2020) -
Encephalitis and Myelitis in a Young Woman: Overlap Syndrome, Thyroiditis, and Occult Tumor From the National Multiple Sclerosis Society Case Conference Proceedings
por: Zarghami Esfanhani, Neda, et al.
Publicado: (2021)